Tetraspanin CD82 regulates transforming growth factor-β signaling in hematopoietic stem and progenitor cells
Molecular Biology of the Cell · 2025
DOI: 10.1091/mbc.e24-10-0474 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology of the Cell, 2025. Verfasst von Erica Pascetti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131. Hauptthemen laut MEDLINE: Hematopoietic Stem Cells, Kangai-1 Protein, Transforming Growth Factor beta. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
The cellular demand of the hematopoietic system is maintained by a rare pool of tissue-specific, hematopoietic stem cells (HSC). HSCs are primarily maintained in a quiescent state but can be activated to exit quiescence and undergo self-renewal and differentiation in response to stress. The cytokine transforming growth factor-β (TGF-β) plays an essential role in supporting HSC quiescence and activation, as one of the most potent inhibitors of hematopoietic stem and progenitor cell (HSPC) growth. Therefore, how TGF-β signaling can be regulated in the context of HSCs is of significant interest as it may uncover novel mechanisms to target HSC activity. Previous studies revealed that the tetraspanin CD82 modulates the long-term HSC population, with CD82 knockout (KO) mice displaying increased HSC activation. Here, in this study, we connect the CD82 scaffold with the regulation of TGF-β signaling in HSPCs. We show that CD82KO leads to decreased TGF-β signaling, whereas increased CD82 expression promotes TGF-β activation. These changes in CD82-mediated TGF-β signaling are associated with extracellular matrix interactions, as fibronectin engagement is critical for promoting TGF-β signaling. Mechanistically, we find that CD82 stimulates enhanced TGF-β activation by promoting receptor cross-talk between TGF-β receptor I and integrin β1, resulting in downstream changes in cell proliferation. Collectively, these findings demonstrate that CD82 modulates canonical TGF-β signaling through receptor cross-talk mechanisms that may be targeted to alter the balance between HSC quiescence and activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131.
- University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Sciences Center, Albuquerque, NM 87131.
Förderung
- NCI NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Pascetti, E., Floren, M., Fernandes, T. D. S., Anastasio, C., Doyle, L., & Gillette, J. (2025). Tetraspanin CD82 regulates transforming growth factor-β signaling in hematopoietic stem and progenitor cells. Molecular Biology of the Cell. https://doi.org/10.1091/mbc.e24-10-0474
Vancouver
Pascetti E, Floren M, Fernandes TDS, Anastasio C, Doyle L, Gillette J. Tetraspanin CD82 regulates transforming growth factor-β signaling in hematopoietic stem and progenitor cells. Molecular Biology of the Cell. 2025. doi:10.1091/mbc.e24-10-0474
BibTeX
@article{Pascetti2025,
author = {Pascetti, Erica and Floren, Muskan and Fernandes, Tatiane da Silva and Anastasio, Carina and Doyle, Levi and Gillette, Jennifer},
title = {Tetraspanin CD82 regulates transforming growth factor-β signaling in hematopoietic stem and progenitor cells},
journal = {Molecular Biology of the Cell},
year = {2025},
doi = {10.1091/mbc.e24-10-0474}
}
EUVIMED